Accountable Revenue Cycle Solutions for Infectious Disease Practices

Relevant revenue cycle work can include workflow review, reporting, revenue leakage identification, payment reconciliation, contract compliance, denial management, claims support, eligibility and authorization, credentialing, payer enrollment, and A/R follow-up. Infectious disease practices may need to coordinate cognitive services with infusion, OPAT, and drug billing, so the most useful approach considers the entire path from referral and documentation through reimbursement and collections.

Infectious disease practices may bill for cognitive services while also managing infusion administration, buy-and-bill drugs, OPAT, specialty therapies, hospital consults, and contracted services. These revenue streams can involve different documentation, coding, authorization, benefit, and payer requirements. A gap in any part of the workflow can delay payment or create unreimbursed costs, making cross-functional review important.

Revenue leakage can be traced through reporting by payer, service line, and provider. Useful reviews look for under-leveled visits, missed drug or administration charges, missing authorization, documentation gaps, contract noncompliance, short-pays, unworked denials, and aging balances. Comparing the work performed with charges submitted and payments received helps identify where revenue was lost, delayed, or left uncollected.

Yes. The service information addresses infusion and OPAT workflows, including eligibility, benefit determination, prior authorization, drug acquisition, administration billing, claims submission, denials, and payment review. Practices can use the guidance to examine whether each site and service is prepared for billing and whether operational handoffs support reimbursement from the first referral through final payment.

Payment reconciliation compares reimbursement received with what should be paid for drug, administration, and E/M claims under applicable payer terms or fee schedules. The review can identify short-pays, incorrect fee schedule application, unit mismatches, NDC issues, and other discrepancies. Findings can then be disputed, tracked, and evaluated for recurring patterns affecting the practice’s balance sheet.

Denial management begins by categorizing denials according to root cause, such as drug or administration coding, missing authorization, medical versus pharmacy benefit confusion, or under-documented consults. Payer-specific appeals can be supported by clinical documentation. Reviewing the findings with clinical, coding, and front-office teams helps address process problems so recurring denials are less likely to continue.

Yes. GrowInfectiousDisease is designed to help practices apply their own numbers rather than rely on generalized rates, margins, or benchmarks. The company states that its calculator tools run in the browser without transmitting or storing user-entered data. Users should still review their inputs carefully and distinguish their practice-specific results from verified external information.

The resources are designed for infectious disease physicians, independent infectious disease practices, infectious disease group leaders, and medical practice administrators. They can support practices evaluating revenue streams, operational decisions, infusion or OPAT programs, staffing, reimbursement, claims performance, and financial sustainability. The guidance is especially relevant when collections do not appear to reflect the work being performed.